Buy AnaptysBio Stock | ANAB Stock Price & Latest News | Public
ANAB

AnaptysBio

$0.00 (0.00%)Today

    About ANAB

    AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its products pipeline include ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    1.05
    0.41
    -0.23
    -0.87
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $1.05

    Actual EPS
    Q4 2020

    Stats

    Market Cap$705,29M
    Volume14,51k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$31.29
    1 Year Low$12.06
    Open$25.59
    High$26.05
    Low$25.23

    Buy any stock with any amount of money.

    Download the App
    Download the app